Introduction {#s1}
============

The Huntington disease (HD) is predominantly inherited, with a single gene, *HTT*, encoding the Huntingtin protein, at its origin ([@bib30]). Mutated and aggregation-prone poly-glutamine-expanded (Poly (Q)) Huntingtins (mHtt) are causing HD by toxic gain-of-functions and, possibly, dominant-negative mechanisms, which are typically manifested in aged individuals ([@bib41]). While the formation of mHtt inclusion bodies (IBs) correlates with toxicity and disease, such formation might, in effect, be a protective response to limit proteotoxicity ([@bib41]; [@bib2]): For example, IB formation predicts improved survival in neurons ([@bib2]) and the IB-forming mHtt103QP protein ([Figure 1a](#fig1){ref-type="fig"}; exon-1 with 97Q repeats) are not, or only mildly, cytotoxic even when produced at high levels in young yeast cells ([@bib14]; [@bib15]). In contrast, when the innate proline-rich region adjacent the poly (Q) stretch of exon-1 is removed, the protein, mHtt103Q, forms multiple small, highly cytotoxic aggregates/oligomers ([Figure 1a](#fig1){ref-type="fig"}) ([@bib14]; [@bib15]; [@bib32]). These aggregates are associated with the actin cytoskeleton ([@bib47]) and interfere with the cytosolic ubiquitin-proteasome-system (UPS) by sequestering the Hsp40 chaperone Sis1 ([@bib38]). Chaperones, peptides, and prion-like proteins that either prevent/modify oligomer production ([@bib5]; [@bib14]; [@bib26]; [@bib37]; [@bib19]) or convert small aggregates/oligomers into IBs ([@bib25]; [@bib56]) can suppress the toxicity of the proline-less exon-1, suggesting that small aggregates and oligomers are likely culprits in mHtt103Q-derived toxicity ([@bib2]; [@bib34]).10.7554/eLife.11792.003Figure 1.Screen approach and mHtt IB-forming mutants.(**a**) Aggregation of different mHtt reporters as indicated. (**b**)Morphology of mHtt103QP aggregates (red) in young and old (1.6 and 12.6 bud scars (white), respectively) cells. Scale=2 μm. Bar graph shows percentages of Class3 cells in young and old cells. Mean ± s.d. (**c**) Schematic description of the HCM-based screen. (**d**) Htt103QP aggregation 0, 60, 120 and 180 min after *HTT103QP* induction. (**e**)Representative pictures of Class 0, 1, 2 and 3 cells. (**f**) Mutants displaying increased% of Class 3 cells, grouped according to functions. Y-axis shows fold increase relative to wild type. (**g**) Physical (red) and genetic (green) interaction between Class 3 genes/proteins and their quantitative interaction (thickness of grey lines) with mHtt103QP as indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.003](10.7554/eLife.11792.003)

Ubiquitination is another process suggested to prevent mHtt toxicity in both mammals ([@bib48]) and yeast ([@bib55]). IBs of mHtt contain ubiquitin in mice ([@bib13]) and the human ubiquitin-conjugating enzyme, hE2-25K, interacts with mHtt, which has been shown to be ubiquitinated in both humans and flies ([@bib24]; [@bib48]). However, an E3 ubiquitin ligase directly responsible for mHtt ubiquitin-tagging, IB formation, and detoxification has not been identified.

Results {#s2}
=======

We approached mHtt toxicity by a different route than recent mHtt103Q toxicity-suppression screens ([@bib25]; [@bib31]; [@bib56]) by asking if the non-toxic, IB-forming mHtt103QP carrying the innate proline-rich stretch of exon-1, requires trans-acting factors to form IBs and if such factors convert mHtt103QP into non-toxic conformers. This approach was prompted also by our finding that the ability to form large and single mHtt103QP IBs was lost upon mother cell aging and the mHtt proteins accumulated instead in multiple, three or more smaller aggregates per cell, referred to as Class 3 cells ([Figure 1b](#fig1){ref-type="fig"}; Class 1 cells contain one aggregate and Class 2 cells contain two aggregates). To identify trans-acting factors required for IB formation in an unbiased genome-wide manner, we used high content microscopy (HCM) and a galactose-regulated version of mHtt103QP, which we introduced into the ordered yeast deletion library (SGA-V2) ([@bib50]) of *S. cerevisiae* ([Figure 1c](#fig1){ref-type="fig"}). Upon galactose-induction, mHtt103QP formed aggregates in about 50% of the cells within 180 min ([Figure 1d](#fig1){ref-type="fig"}) and 70% of these cells contain one large IB. HCM was used to identify mutants that formed multiple aggregates/oligomers rather than a big IB (Class 3 mutants; [Figure 1e](#fig1){ref-type="fig"}), which revealed that IB formation requires proteasome/chaperone and ubiquitination functions, Golgi-vesicle trafficking, mRNA transport/metabolism, and cell cycle control ([Figure 1f&g](#fig1){ref-type="fig"}, see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"} for a list of confirmed mutants). Among these factors, Ltn1 and Rqc1 are especially interesting as they are both partners of the ribosome quality control complex (RQC) ([@bib9]) and Ltn1 is the yeast homologue of the E3 RING ubiquitin ligase Listerin of mammalian cells ([@bib6]), which reduced activity causes premature neurodegeneration in mice ([@bib11]).

Complementation analysis revealed that the ubiquitin E3 ligase activity of Ltn1 was required for both mHtt103QP IB formation ([Figure 2a](#fig2){ref-type="fig"}) and ubiquitination ([Figure 2b](#fig2){ref-type="fig"}). It's been reported that the absence of Ltn1, but not Rqc1, results in the failure to tag non-stop protein with ubiquitin ([@bib9]). Contrasting such data on non-stop proteins, both Ltn1 and Rqc1-deficieny resulted in a failure of cells to tag also full-length mHtt103QP properly with ubiquitin ([Figure 2b](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and to form IBs, even though the effect of *rqc1∆* was markedly smaller than *ltn1∆* on IB formation ([Figure 2a](#fig2){ref-type="fig"}). Moreover, both soluble and aggregated mHtt103QP was stable in the absence and presence of Ltn1 ([Figure 2c](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}), and the levels of soluble and aggregated mHtt103QP was somewhat lower in *ltn1∆* cells ([Figure 2---figure supplements 2 & 4](#fig2s2){ref-type="fig"}). These data suggest that Ltn1 is involved in mHTT103QP sequestration into IBs rather than its decay.10.7554/eLife.11792.004Figure 2.Role of RQC in mHtt103QP IB formation ubiquitination and toxicity.(**a**, **d**)Htt103QP aggregate numbers (% Class 1,2&3 cells; see [Figure 1](#fig1){ref-type="fig"}) in mutants as indicated. W1542E encodes a ubiquitin-ligase-defect Ltn1 protein. *HSF1-R206S* encodes a hyper-active Hsf1. The *hsf1-848* is a conditional *ts* mutant while *HSF1ΔCAD* lacks the c-terminal trans-activating domain. Scale=2 μm. Bar graphs show % of Class 1, 2 and 3 cells in each strain. Mean ± s.d. (**b**)Ubiquitination of mHtt103QP in strains from '**a'.** (**c**) Htt103QP stability in WT and *ltn1Δ* cells after a block in protein synthesis. Mean ± s.d. **e-g.** Fitness (see Materials and methods) of strains carrying pYES2-mHtt103QP-GFP compared to pYES2-GFP. Results from Galactose (mHtt induced) and Glucose (mHtt repressed) are shown. Ratios were calculated from the mean of three repeats (error bars are 95% confidence intervals) for WT, RQC, and *rnq1∆* mutants (**e**) *HSF1-R206S* (**f**) and *hsf1-848* (**g**).**DOI:** [http://dx.doi.org/10.7554/eLife.11792.004](10.7554/eLife.11792.004)10.7554/eLife.11792.005Figure 2---figure supplement 1.Western blot of His-Ub pull-down mHtt103QP in RQC mutants.mHtt103QP-GFP ubiquitinated by His-tagged ubiquitin was pulled-down by Ni-beads and detected by GFP antibody.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.005](10.7554/eLife.11792.005)10.7554/eLife.11792.006Figure 2---figure supplement 2.FRAP assay of mHtt103QP aggregate in Wt and RQC mutants.(**a**) Representative images of mHtt103QP-GFP aggregate before and after laser bleach. (**b**) Relative fluorescence of the bleached region.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.006](10.7554/eLife.11792.006)10.7554/eLife.11792.007Figure 2---figure supplement 3.Ltn1-GFP co-localize with mHtt103QP-mRFP.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.007](10.7554/eLife.11792.007)10.7554/eLife.11792.008Figure 2---figure supplement 4.mHtt levels chase after cycloheximide treatment.(**a**) Representative Western blots of soluble and aggregated mHtt103QP from Wt and *ltn1Δ* strains. (**b**) Quantitafication of three repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.008](10.7554/eLife.11792.008)10.7554/eLife.11792.009Figure 2---figure supplement 5.mHtt103QP aggregate in *ltn1Δtae2Δ* is also co-localized with dense actin structures.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.009](10.7554/eLife.11792.009)

Ltn1-, and to a lesser extent, Rqc1-deficieny results in hyper-activation of the heat shock transcription factor Hsf1 through the RQC component Tae2 and such activation can thus be suppressed by removing the *TAE2* gene ([@bib9]). We found that deleting *TAE2* in *ltn1∆* or *rqc1∆* cells restored IB formation ([Figure 2a](#fig2){ref-type="fig"}, [Figure 2---figure supplements 2 & 5](#fig2s2){ref-type="fig"}) but did not restore ubiquitination ([Figure 2b](#fig2){ref-type="fig"}), demonstrating that ubiquitination is not an absolute requirement for the formation of mHtt103QP IBs. Moreover, overproducing a hyperactive Hsf1 (*HSF1-R206S *\[[@bib21]\]) alone was sufficient to reduce IB formation, as was reducing Hsf1 activity using the *hsf1-848*(ts) allele ([Figure 2d](#fig2){ref-type="fig"}). demonstrating that maintaining a proper, intermediate, range of Hsf1 activity is required to efficiently sequester mHtt103QP into IBs. In support of this notion, a deletion in the C-terminal trans-activation domain of Hsf1 resulted in defects in IB formation that could not be further abrogated by an *ltn1* deletion ([Figure 2d](#fig2){ref-type="fig"}).

The mHtt103QP protein displays no obvious toxicity in yeast ([@bib14]; [@bib15]) but we found that it became detrimental in the absence of Ltn1, and to a somewhat lesser extent, Rqc1 ([Figure 2e](#fig2){ref-type="fig"}), supporting the idea that IB formation protects the cell against Huntingtin toxicity. Consistently, a *tae2∆* mutation completely suppressed the toxicity of mHtt103QP in the *ltn1∆* cells ([Figure 2e](#fig2){ref-type="fig"}). Since the *TAE2* deletion did not restore mHtt103QP ubiquitination, we conclude that IB formation is more important than ubiquitination for the detoxification of mHtt103QP, at least in the yeast model system. Contrasting the *LTN1* data, the absence of *TAE2* failed to fully suppress toxicity in *rqc1∆* cells indicating that the roles of Ltn1 and Rqc1 in RQC are overlapping ([@bib9]) but not identical. Consistent with small mHtt103QP aggregates/conformers being toxic, both overactive and diminished Hsf1 activity rendered mHtt103QP toxic ([Figure 2f&g](#fig2){ref-type="fig"}). Since the proline-less, intrinsically noxious, mHtt103Q protein requires the presence of the prion-forming protein Rnq1 to display cytotoxicity in yeast ([@bib32]), we tested whether the toxicity of mHtt103QP in Ltn1-deficient also required the presence of Rnq1 and found that this was not the case ([Figure 2e](#fig2){ref-type="fig"}).

The small cytotoxic mHtt103Q aggregates have been shown to associate with the actin cytoskeleton ([@bib47]), and we, therefore, investigated if mHtt103QP in wild type and *ltn1∆* cells likewise interacted with and affected actin cytoskeletal structures. First, using co-staining with the misfolded protein Ubc9^ts^-mCherry, we confirmed that the mHtt103QP proteins of wild type cells were deposited in IBs adjacent to the Ubc9^ts^-associated insoluble-protein-deposit, IPOD ([@bib23]) ([Figure 3a](#fig3){ref-type="fig"}). Super resolution, three-dimensional structured illumination microscopy (SIM) revealed that these mHtt103QP IBs were associated with dense actin cytoskeletal structures ([Figure 3b](#fig3){ref-type="fig"}, [Video 1](#media1){ref-type="other"}). Moreover, the actin cytoskeleton appears to harness latent mHtt103QP toxicity as a screen for conditional *ts* mutations causing synthetic sickness/lethality with mHtt103QP ([Figure 3d&e](#fig3){ref-type="fig"}) revealed that cells carrying *ts* mutations in genes encoding actin itself (*act1*), profiling (*pfy1*) involved in actin polymerization, cofilin (*cof1*) regulating assembly/disassembly of actin filaments, Arp3 of the actin-nucleation center, Las17, an activator of Arp2/3 and actin assembly factors, and Mss4, a phosphatidylinositol-4-phosphate 5-kinase involved in actin cytoskeleton organization, were drastically sensitized to mHtt103QP ([Figure 3d&e](#fig3){ref-type="fig"}, also see [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} for a list of alleles). The multiple mHtt103QP aggregates formed in *ltn1∆* cells also co-localized with actin cytoskeletal structures ([Figure 3c](#fig3){ref-type="fig"}, [Video 2](#media2){ref-type="other"}), akin to those of the toxic mHtt103Q aggregates reported previously ([@bib47]). Actin-mHtt103QP-associated structures were more abundant in Ltn1-deficient cells than in wild type cells whereas the number of aggregate-free forms of actin structures, including actin patches, was reduced ([Figure 3f](#fig3){ref-type="fig"}). Because the actin cytoskeleton is required for proper endocytosis, we tested the effect of mHtt103QP and an *ltn1* deletion on the rate of endocytic internalization of the dye FM4-64, and found that Htt103QP retarded endocytosis and that such retardation was more pronounced in cells lacking Ltn1 ([Figure 3g](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In contrast, Ltn1 deficiency did not by itself cause actin cytoskeleton defects or endocytosis retardation ([Figure 3g](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).10.7554/eLife.11792.010Figure 3.Role of actin in Htt103QP detoxification.(**a**)Co-localization of mHtt103QP IBs and UBC9^ts^ IPODs. (**b**, **c**) Actin structures (Red; phalloidin) and mHtt103QP (Green; GFP) aggregates in WT and *ltn1Δ* analyzed by 3D-SIM. Scale=1 μm. (**d**)Essential *ts*-alleles increasing toxicity of mHtt103QP, grouped according to biological processes. (**e**) Functional enrichment analysis of mHtt103QP-sensitive *ts* mutants. (**f**) Number of actin-associated aggregates and aggregate-free actin structures in WT and *ltn1Δ* cells. Mean ± s.d. **g.** Endocytotic activity in WT and *ltn1Δ* cells analyzed by FM4-64FX uptake to vacuoles. Mean ± s.d. (**h**)A model of the regulation of mHtt103QP IB formation and toxicity by RQC components and Hsf1.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.010](10.7554/eLife.11792.010)10.7554/eLife.11792.011Figure 3---figure supplement 1.FM4-64FX stained cells.Images of FM4-64FX stained cells corresponding to [Figure 3g](#fig3){ref-type="fig"}.Representative cells carrying pYES2-GFP (\'Vector\') or pYES2-mHtt103QP-GFP (\'103QP\') were shown.ltn1Δ.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.011](10.7554/eLife.11792.011)10.7554/eLife.11792.012Figure 3---figure supplement 2.Actin integrity of Wt and a. Actin staining of Wt and *ltn1Δ* cells, b. Quantification of actin depolarization of Wt and *ltn1Δ* cells, see Materials and methods for details.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.012](10.7554/eLife.11792.012)Video 1.3D structures of mHtt103QP aggregate and actin in *WT*.mHtt103QP aggregates (green) and actin (red) structures of a *WT* cell shown in [Figure 3b](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.013](10.7554/eLife.11792.013)10.7554/eLife.11792.013Video 2.3D structures of mHtt103QP aggregate and actin in *ltn1Δ*.mHtt103QP aggregates (green) and actin (red) structures of a *ltn1Δ* cell shown in [Figure 3c](#fig3){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.11792.014](10.7554/eLife.11792.014)10.7554/eLife.11792.014

Discussion {#s3}
==========

The conserved Listerin (Ltn1) E3 ligase is a key factor involved in targeting protein products derived from defective mRNA or aborted translation for degradation by the 26S proteasome ([@bib6]; [@bib9]). Upon translation stalling, ribosome recycling factors dissociate 80S ribosome-nascent chain complexes to 60S ribosome-nascent chain-tRNA complexes, which are recognized by Ltn1 and Tae2 ([@bib45]; [@bib44]; [@bib43]). Both nascent chains and, for example, K12- and R12-arrested polypeptides are substrates for Ltn1-dependent ubiquitin tagging, which signal their destruction by the 26S proteasome ([@bib6]; [@bib9]; [@bib39]). Herein, we report on another pivotal role of Ltn1 in protein quality control -- detoxification of mutant Huntingtin through a Tae2/Hsf1-dependent sequestration of mHtt103QP into actin-associated inclusions ([Figure 3h](#fig3){ref-type="fig"}). As depicted in [Figure 3h](#fig3){ref-type="fig"}, the effect of Ltn1 on mHtt103QP aggregation appears to act through Tae2, which in turn is known to negatively control Hfs1 activity ([@bib9]). Thus, the presence of Tae2 is known to cause hyperactivation of Hsf1 when *LTN1* is deleted ([@bib9]), which could be enough to inhibit IB formation. On the other hand, mutations reducing Hsf1 activity also inhibited IB formation suggesting that maintaining a proper, intermediate, range of Hsf1 activity is required to efficiently sequester mHtt103QP into IBs ([Figure 3h](#fig3){ref-type="fig"}). In worms, elevated production of small heat shock proteins through Hsf1 activity has been shown to delay the onset of polyglutamine-expansion protein aggregation ([@bib22]) and reducing *hsf-1* activity accelerates aging ([@bib22]; [@bib36]). Reciprocally, *hsf-1* overexpression extends worm lifespan ([@bib22]). ([@bib4]). The data presented here, however, demonstrate that both Hsf1 elevation and Hsf1 deficiency in cells expressing the Huntingtin disease protein is detrimental ([Figure 3h](#fig3){ref-type="fig"}), suggesting, again, that a fine balance of Hsf1 activity has to be maintained to assuage proteotoxicity. This notion might explain why alterations in Hsf1 levels in mammalian cells have been shown to either inhibit mHtt IB formation ([@bib18]) or lower the concentration threshold at which HTT forms IB ([@bib7]). These results raise the question of whether age-dependent penetrance of HD could be due to a reduced Hsf1 activity in aging tissues or a malignant hyperactivation of Hsf1. The latter scenario could be the result of an age-dependent increase in translational processivity errors, which could titrate the RQC complex eliciting a Tae2-dependent activation of Hsf1 ([Figure 3h](#fig3){ref-type="fig"}), possibly through Tae2-directed tagging of incomplete translation products with carboxyl-terminal Ala and Thr extensions. ([@bib45]).

The exact mechanism behind Hsf1-dependent modulation of mHtt IB formation might be complex in that Hsf1 targets other genes than heat shock genes. It has been shown in worms that over-expression of hsf-1, with or without the C-terminal trans-activation domain, elevates the levels of pat-10, a troponin-like protein, that increase actin cytoskeleton integrity leading to lifespan extension and resistance to proteotoxic stress ([@bib4]). Thus, it is possible that Hsf1 may regulate mHtt IB formation/toxicity in the yeast model system through the regulation of actin cytoskeleton dynamics since we found that mHtt103QP is associated with dense actin structures and that genes involved in actin dynamics are required to harness the latent toxicity of mHtt103QP. In addition, our data cannot rule out the possibility that the expression of mHtt in general raises proteostasis stress in the cell leading to Hsf1 activation and that such activation is epistatically affecting the effect of Ltn1-deficieny.

Materials and methods {#s4}
=====================

Plasmids, yeast strains, and growth conditions {#s4-1}
----------------------------------------------

Plasmids and yeast strains used in each assay and figure were specified in [Supplementary file 3A and B](#SD3-data){ref-type="supplementary-material"}.

Yeast cells were grown at 30°C if not specified, in YPD (BY4741 background), YPAD (W303 background) or corresponding synthetic drop-out media with antibiotics. For all galactose induction experiments, yeast cells were pre-cultured, diluted, and re-grown in media with 2% raffinose until mid-log phase (OD600=0.5). 2% galactose was then added to induce expression for desired time. For temperature sensitive strains (except Ubc9^ts^, see below), cells were pre-cultured at 22°C and switched to 30°C during experiments.

HSF1 and HSF1ΔCAD in the W303-1A background (as described in \[[@bib16]\]) was a gift from Dr. H Nelson (University of Pennsylvania, USA). The mHtt103QP plasmid pYES2-103QP-GFP (as described in \[[@bib33]\]) was a gift from Dr. M Sherman (Boston University, USA). Plasmid pYES2-GFP (as described in \[[@bib40]\]) was a gift from Dr. C Forestier (CEA, France). Plasmids pGAD-HA-Ltn1 and pGAD-HA-Ltn1-1542E (as described in \[[@bib6]\]) were gifts from Dr. CJoazeiro (The Scripps Research Institute, USA). Plasmid pRS416-TEF1-Hsf1M (as described in \[[@bib21]\]) was a gift from Dr. J Nielsen (Chalmers University of Technology, Sweden). Plasmid pADH-His-Ub ([@bib29]) was a gift from Dr. S Jentsch (Max Planck Insititute of Biochemistry, Germany).

Strain and plasmid constructions {#s4-2}
--------------------------------

The pYES2-mHtt103QP-GFP plasmid was transformed to SGA-V2 single gene knock-out collection by a robotic SGA procedure to generate the strain collection SGA-V2-pYES2-mHtt103QP-GFP (S2Y103QPG) for HCM-based screen ([@bib50]; [@bib51]). A control plasmid pYES2-GFP was also transformed to SGA-V2 collection to build [S]{.ul}GA-V[2]{.ul}-p[Y]{.ul}ES2-[G]{.ul}FP (S2YG) collection as negative controls for toxicity assays.

*ltn1Δ::natMX4* in BY4741, W303 and W303 *HSF1ΔCAD*, SGA *rnq1Δ* backgrounds and *tae2Δ::natMX4* in SGA *rqc1Δ* and SGA *ltn1Δ* backgrounds were all generated by PCR-mediated gene deletion.

The coding sequence of URA3 in pYES2-mHtt103QP-GFP and pYES2-GFP were replaced by hphMX4 cassette via PCR-mediated gene deletion, to generate pY2H-mHtt103QP-GFP and pY2H-GFP plasmids to make them compatible with URA3 plasmids. The template used to amplify hphMX4 is plasmid pAG32 ([@bib20]).

Isolation of old cells {#s4-3}
----------------------

Isolation of old cells was carried out via the biotin-streptavidin magnetic beads binding system as previously described ([@bib46]). Old cells (\'Old\' in [Figure 1b](#fig1){ref-type="fig"}) were labeled with EZ-Link NHS-Biotin (Thermo Fisher Scientific, Waltham, MA), first aged in glucose media for two overnights and then in raffinose media for one overnight before harvesting; young cells (\'Young\' in [Figure 1b](#fig1){ref-type="fig"}) were the progenies of the old cells generated in the last overnight culturing in raffinose media. Both young and old cells were induced for mHtt103QP-GFP expression for 3 hr and then fixed. Mean ages of samples were assessed by counting bud scars stained by Calcofluor white (Sigma-Aldrich, St. Louis, MO). Three parallel repeats were performed.

HCM-based screen {#s4-4}
----------------

Each strain from the S2Y103QPG collection was pre-cultured, induced for mHtt103QP-GFP expression as described earlier and fixed with 3.7% formaldehyde at room temperature for 30 min in 96-well plates. For image capturing, appropriate amount of fixed cells were transferred to new 96-well plates and imaged with the ImageXpress MICRO (Molecular Devices, Sunnyvale, CA), an automated cellular imaging system. Customized sub-program of the software MetaXpress (Molecular Devices) was applied on the obtained images for quantification. All mutants that showed statistically significant increase larger than three times the variance of the wild type were restreaked and re-tested individually and analyzed manually to confirm the phenotypic differences observed in the screen. At least 300 cells were counted in the manual confirmation.

Microscopy {#s4-5}
----------

Cell images (except for 3D-SIM images in [Figure 3b&c](#fig3){ref-type="fig"}) were obtained via Zeiss Axio Observer.Z1 inverted microscope and Zen Pro 2012 software (Carl Zeiss AG, Germany). Filter sets used are: 38 HE GFP for mHtt103QP-GFP, 43 HE DsRed for Ubc9^ts^-MCherry, 45 Texas Red for FM4-64FX and 49 DAPI for DAPI and Calcofluor white. Images in [Figure 1b](#fig1){ref-type="fig"} and [Figure 3a](#fig3){ref-type="fig"} were deconvolved by ImageJ software and plugin \'Iterative deconvolve 3D\', maximum number of iterations set to 15 and 10 respectively.

IB morphology tests were performed three times for each strain in [Figure 1b](#fig1){ref-type="fig"}, [Figure 2a, d](#fig2){ref-type="fig"}; 100 cells with aggregates were analyzed and quantified for each repeat.

Immunoprecipitation (IP) and Western blot {#s4-6}
-----------------------------------------

Whole cell protein extracts were obtained via mild alkali treatment and IPs by anti-FLAG M2 affinity gels (Sigma) were carried out following previously published protocols ([@bib6]). mHtt103QP-GFP was expressed for 3 hr in all samples. Western blotting was done as described before ([@bib35]) using an XCell SureLock MiniCell (LifeTechnologies) and Immobilon-FL PVDF membranes (Millipore, Billerica, MA). Ubiquitination signals were detected by a rabbit polyclonal anti-ubiquitin antibody (ab19247; AbCam, United Kingdom). The mHtt103QP-GFP was detected by a chicken polyclonal anti-GFP antibody (ab13970; AbCam).

mHtt103QP-GFP stability assay {#s4-7}
-----------------------------

The stability of in vivo mHtt103QP-GFP by FACS was determined by the change of GFP fluorescent signal strength after inhibition of protein synthesis by cycloheximide, as described previously ([@bib47]).

Soluble protein and protein aggregates were separated by ultracentrifugation as described in ([@bib47]) and then quantified by Western blotting. mHtt protein levels were standardized to total protein levels determined by Coomassie Brilliant Blue staining of the membrane.

Doubling time determinations {#s4-8}
----------------------------

Doubling time was determined by the Bioscreen Assays as described ([@bib54]), in media with either 2% glucose or 2% galactose after overnight pre-culturing in media containing 2% raffinose as the only carbon source. Three parallel replicates were run for each strain.

Actin staining {#s4-9}
--------------

Actin structures were stained by Alexa568-phalloidin (Thermo Fisher Scientific) as described ([@bib28]). For quantifications in [Figure 3f,](#fig3){ref-type="fig"} Z-stack serial images were analyzed. To avoid possible bias caused by different distributions of cells at different cell cycle stages, only mother cells in budding events with undivided nucleus (determined by DAPI staining) were counted ([@bib1]).

Localization of mHtt103QP aggregates {#s4-10}
------------------------------------

Both mHtt103QP-GFP and Ubc9^ts^-mCherry were expressed for 3 hr at 28°C. The cells were then incubated at 37°C for 30 min to trigger Ubc9^ts^ aggregate formation. Cells were fixed and washed immediately after the 37°C treatment.

3D-SIM microscopy {#s4-11}
-----------------

3D-SIM microscopy images were obtained as previously reported ([@bib47]).

SGA analysis {#s4-12}
------------

SGA analysis of the ts-allele collection was performed and scored as previously described ([@bib52]; [@bib12]; [@bib27]). The cut-off for the screen was -0.5 in score from the screen.

Functional enrichment and network analysis {#s4-13}
------------------------------------------

The functional enrichment analysis of Htt103QP essential synthetic sick interactors was based on the result from Gene Ontology Term Finder ([@bib8]) using the SGA ts-V5 array (787 ts alleles, covering 497 essential genes) as the background list.

Cytoscape 3.2.0 ([@bib42]) was used for interaction network analysis of hits with increased class 3 aggregates. The physical interactions between the hits were obtained from BioGRID interaction database ([@bib10]) using GeneMANIA plugin ([@bib53])

Assessment of actin depolarization and endocytosis {#s4-14}
--------------------------------------------------

Actin depolarization was quantified as described in ([@bib1]).

Endocytosis was assessed by tracking FM4-64FX (Thermo Fisher Scientific) internalization in live cells as described ([@bib3]) with minor modifications. Yeast cells were strained on ice for 30 min with FM4-64FX after 3 hr expression of mHtt103QP-GFP. Cells were then incubated in YPD at 30°C in dark. Z-stack images of samples taken after 0, 15, 30, 45 and 60 min incubation at 30°C were captured and analyzed.

Flourescence recovering after photobleaching (FRAP) assay {#s4-15}
---------------------------------------------------------

FRAP of mHtt103-QP aggregates was carried out on LSM 700 Axio Observer.Z1 (Carl Zeiss). Images were captured every second for 90 s after photobleaching. Fluorescent intensities of the bleached region were quantified via ImageJ.

His-Ub pull-down assay {#s4-16}
----------------------

His-Ub pull-down assay was carried out as described in ([@bib49]) with minor modifications. His-tagged Ub was expressed from pADH-His-Ub and pulled down via Dynabeads His-tag (Thermo Fisher Scientific).

Statistics {#s4-17}
----------

For bar graphs in [Figure 1b](#fig1){ref-type="fig"}, [2a](#fig2){ref-type="fig"}, [2d](#fig2){ref-type="fig"}, [3f](#fig3){ref-type="fig"}, [3g](#fig3){ref-type="fig"}, data shown are mean of three replicates ± s.d., unpaired two-tailed t-test was used to compare mean values. Statistical significance was indicated as \*p\<0.05; \*\*p\<0.01; \*\*\* *P*\<0.001.

For the bar graph in [Figure 2 e-g](#fig2){ref-type="fig"}, data shown is the ratio of means ± 95% confidence interval. The confidence intervals were calculated based on Fieller's theorem ([@bib17]) by an online-calculator <http://www.graphpad.com/quickcalcs/ErrorProp1.cfm> (GraphPad Software, La Jolla, CA).
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Decision letter

Dillin

Andrew

Reviewing editor

Howard Hughes Medical Institute, University of California, Berkeley

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Spatial sequestration and detoxification of Huntingtin by the ribosome quality control complex\" for consideration by *eLife*. Your article has been favorably evaluated by Naama Barkai (Senior editor) and three reviewers, one of whom, Andrew Dillin, is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

In this manuscript the authors investigate factors that influence the formation and toxicity of inclusion bodies (IB) formed upon expression of mutated Huntingtin protein (mHtt) with polyglutamine expansions in yeast. They identified components of the ribosome quality control complex (RQC), namely Ltn1, a ribosome-associated E3-ubiquitin ligase, together with Tae2 and the Hfs1, as key factors that affect IB formation and toxicity of mHtt. Loss of Ltn1 and Tae2 or a misregulation of Hsf1-activity provoked the formation of multiple mHtt aggregates instead of one large IB and a reduction in cell growth. In addition, using super-resolution microscopy, the authors showed that multiple and disperse mHtt aggregates alter the actin cytoskeleton and retard endocytosis processes.

While all three reviewers are excited about the work and its implications for the field, there are three major points that need to be addressed:

1\) The ubiquitination experiments need to be performed with His-ubiquitin pull-down analysis from RQC deficient cells expressing mHtt.

2\) Does Ltn1 deficiency cause abnormal actin cytoskeletal structures and reduced endocytosis independently of mHtt expression? How does their model fit with published data of Hsf1 and cytoskeletal dynamics?

3\) The role of *HSF1* in this process could be direct as proposed, but also could be very indirect. It is suggested that the authors suggest alternative possibilities in their proposed models.

Finally, the idea that ribosomes could stall on repeat mRNAs, such as PolyQ containing, to elicit the RQC pathway is very interesting. All three reviewers feel that a direct demonstration of this stalling event on PolyQ mRNA would solidify the model, but we also felt that this might be a technically challenging experiment due to the repeat nature of the mRNA and alignment of the profile reads onto the correct message. Can the authors comment on the feasibility of this type of experiment?

*Reviewer \#1:*

The dynamics and toxicity of PolyQ containing proteins is fascinating and not well understood. Here, the authors compare two forms of polyQ containing proteins (103Q) that differ by an internal proline region. The toxic form, lacking the P-rich region, forms small aggregates and the less toxic form, containing the P-rich domain forms a single large inclusion body. Asking if the IB formation is an active process, the group has screened for mutants that convert the IB into smaller bodies. The group focuses on Ltn1 and Rqc1 mutations, both of which have been identified for their role in ribosome associated protein quality control. Conversion of the smaller aggregates corresponds with increased toxicity and loss of Tae2, a downstream effector of Ltn1/Rqc1 suppresses both aggregate formation and toxicity.

One of the most interesting points of this work is the ability to accurately control toxic aggregate formation independent of ubiquitination of Htt. This is also the weakest point of the manuscript and few minor experiments will shore up the results. These include ubiquitin pull down experiments and probing for levels of Htt in the different mutant backgrounds.

Another interesting and unexpected finding is that loss of Tae2 in the Ltn1 mutant background restores IB formation and reduces toxicity. The main question to understand is whether the IB formed in the case is identical to the IB formed in the wild type setting (i.e. it is not ubiquitinated). It would excellent if solubility of the IBs could be measured (FRAP analysis for example). Also, are the IBs found in the ltn1 tae2 mutant also wrapped in actin cables?

Finally, the role of Hsf1 in this process is not fully detailed or alternative possibilities suggested. One thought to explain the dose dependency observed here could involve the idea that Hsf1 is a repressor of ltn1 or rqc1 expression. The analysis with the transactivation domain mutation of Hsf1 cannot address this possibility.

*Reviewer \#2:*

Summary:

In this interesting study the authors have identified components involved in inclusion body (IB) formation of polyglutamine expanded huntingtin fragments (mHtt) through a genome-wide screen in yeast. They find that the ribosomal quality control complex (RQC) proteins, Ltn1 and Rqc1, are associated with the spatial sequestration of mHtt proteins and proteotoxicity. RQC deficient cells no longer sequester mHtt into IBs and this is attributed to over-activation of the heat stress response.

General comments:

The authors have presented the surprising finding that RQC deficiency renders cells deficient in sequestering mHtt proteins into IBs. This effect correlates with toxicity. However, the current manuscript does not differentiate between a direct or indirect role of RQC components in IB formation. RQC deficient cells may have a general proteostasis impairment resulting in failure of the actin cytoskeleton to mediate IB formation. Such proteostasis impairment may not occur (or be less pronounced) in the *TAE2* deletion strain, consistent with the absence of *HSF1* activation in that strain (Brandman et al.). The finding that *HSF1* activation (or suppression) reduces IB formation independently of RQC deficiency could be merely correlative. These aspects should be discussed in more detail. Another important question relates to the interesting possibility that Ltn1 is directly involved in mHtt ubiquitination (also see below).

Specific comments:

1\) Data quality of mHtt ubiquitination in [Figure 2B](#fig2){ref-type="fig"} should be improved. His-ubiquitin pull-down analysis from RQC deficient cells expressing mHtt could be used.

2\) Biochemical analysis following cycloheximide chase or metabolic chase should be performed to determine the stability of mHtt in *ltn1* deletion cells.

3\) Does Ltn1 deficiency cause abnormal actin cytoskeletal structures and reduced endocytosis independently of mHtt expression?

4\) What is the cut-off criteria for the HCM-based screen in [Supplementary files 1](#SD1-data){ref-type="supplementary-material"} and [2](#SD2-data){ref-type="supplementary-material"}?

*Reviewer \#3:*

In this manuscript the authors investigate factors that influence the formation and toxicity of inclusion bodies (IB) formed upon expression of mutated Huntingtin protein (mHtt) with polyglutamine expansions in yeast. They identified components of the ribosome quality control complex (RQC), namely Ltn1, a ribosome-associated E3-ubiquitin ligase, together with Tae2 and the Hfs1, as key factors that affect IB formation and toxicity of mHtt. Loss of Ltn1 and Tae2 or a misregulation of Hsf1 activity provoked the formation of multiple mHtt aggregates instead of one large IB and a reduction in cell growth. In addition, using super-resolution microscopy, the authors showed that multiple and disperse mHtt aggregates alter the actin cytoskeleton and retard endocytosis processes.

This is a very elegant study and the findings reported in this manuscript are new and very exciting. However, there are a few points that the authors should address prior to publication.

1\) Ltn1 and other RQC components associate with disassembled 60S subunits that carry stalled nascent chains which are ubiquitinated by Ltn1 and turned over by the proteasome (Bengtson & Joazeiro, 2010). In this manuscript it remains unclear whether Ltn1 and other components of the RQC contribute directly or indirectly to the change in aggregate morphology and size and the toxicity of mHtt. Different scenarios are possible that are not mutually exclusive:

Expression of mHtt itself may cause stalling of translation and the production of truncated mHtt versions may induce Hsf1. Both, Hsf1 activity and truncated mHtt polypeptides, may contribute to alter aggregate morphology and mHtt toxicity.

Alternatively, expression of mHtt may challenge proteostasis in a more general manner (e.g. chaperone activities, proteasome activities etc.) and generally enhance stalling events that are handled by the RQC and induce Hsf1 activity. Thus, is it merely an indirect effect through HSR activation, followed e.g. by an increase in molecular chaperones, that holds the mHtt aggregates in an oligomeric, toxic state?

Further experimental analysis could shed some light on this issue. Does synthesis of mHtt (103QP) cause an arrest in translation and thus activate the RQC? Do truncated mHtt products occur in the absence of Ltn1? Is Ltn1 perhaps recruited from the ribosome to the mHtt1 aggregates? Does expression of mHtt generally enhance stalling frequency? To address these points, the authors can investigate stalling of mHtt via Western Blotting by expressing an N-terminally tagged version of mHtt in the presence and absence of Ltn1. Moreover, they can test for the stalling of a model protein (e.g. by 12Ks) during mHtt expression and for the association of Ltn1 with mHtt aggregates, e.g. by co-immunoprecipitation or co-localization in vivo.

In this context, recent publications that reconstitute the ubiquitination pathway at the ribosome and solved crystal structures of Ltn1 associated with 60S-RNCs should be considered briefly in the discussion (Shao & Hegde, 2013; Shao et al., 2015; Lyumkis et al., 2014; Shen et al. 2015).

2\) This point relates to data shown [Figure 2B and 2C](#fig2){ref-type="fig"}:

[Figure 2B](#fig2){ref-type="fig"} shows the ubiquitination of mHtt (103QP). It is unclear whether ubiquitination of soluble or aggregated 103QP is detected in the blot. Is this really ubiquitination of full-length mHtt (103QP) or of a truncated mHtt arrest product? Why is the ubiquitin signal different in wt compared to *tae2∆*? Could this argue for truncated mHtt products that lack the cat tail in tae2 mutant cells (see Shen et al., Science 2015)?

Please also include an immunoblot monitoring Ltn1 expression levels, especially when expressed from a plasmid.

[Figure 2C](#fig2){ref-type="fig"} shows the stability of mHtt in wt and ltn1∆ cells and the authors conclude that mHtt was equally stable in both strains. Does the readout include soluble AND/OR aggregated mHtt species? The readout was done by GFP activity (fused to mHtt). Thus, it may mainly report on insoluble aggregates of mHtt which show also GFP activity and of course remain rather stable! Moreover, the mHtt portion might be degraded by the proteasome but not the folded GFP moiety.

This experiment has to be re-designed to look directly to mHtt in the soluble vs. aggregated fraction in the presence and absence of Ltn1.

10.7554/eLife.11792.019

Author response

*In this manuscript the authors investigate factors that influence the formation and toxicity of inclusion bodies (IB) formed upon expression of mutated Huntingtin protein (mHtt) with polyglutamine expansions in yeast. They identified components of the ribosome quality control complex (RQC), namely Ltn1, a ribosome-associated E3-ubiquitin ligase, together with Tae2 and the Hfs1, as key factors that affect IB formation and toxicity of mHtt. Loss of Ltn1 and Tae2 or a misregulation of Hsf -activity provoked the formation of multiple mHtt aggregates instead of one large IB and a reduction in cell growth. In addition, using super-resolution microscopy, the authors showed that multiple and disperse mHtt aggregates alter the actin cytoskeleton and retard endocytosis processes. While all three reviewers are excited about the work and its implications for the field, there are three major points that need to be addressed: 1) The ubiquitination experiments need to be performed with His-ubiquitin pull-down analysis from RQC deficient cells expressing mHtt.*

The pull-down experiment has been performed as suggested and the data further support our conclusions concerning mHtt103QP ubiquitination. Please see [Figure 2](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.

*2) Does Ltn1 deficiency cause abnormal actin cytoskeletal structures and reduced endocytosis independently of mHtt expression? How does their model fit with published data of Hsf1 and cytoskeletal dynamics?*

We show that Ltn1 deficiency does not by itself cause abnormal actin cytoskeletal structures ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) or reduce endocytosis ([Figure 3G](#fig3){ref-type="fig"}, the "vector" controls) but is rather epistatic to mHtt103QP expression.

We have added a discussion on, and reference to, the previously demonstrated role of Hsf1 in affecting actin cytoskeletal dynamics.

*3) The role of HSF1 in this process could be direct as proposed, but also could be very indirect. It is suggested that the authors suggest alternative possibilities in their proposed models.*

We agree and have added a discussion on this as suggested.

*Finally, the idea that ribosomes could stall on repeat mRNAs, such as PolyQ containing, to elicit the RQC pathway is very interesting. All three reviewers feel that a direct demonstration of this stalling event on PolyQ mRNA would solidify the model, but we also felt that this might be a technically challenging experiment due to the repeat nature of the mRNA and alignment of the profile reads onto the correct message. Can the authors comment on the feasibility of this type of experiment?*

We agree with the reviewers on the technical difficulty of such experiments and even if possible, it would most likely take much too long to get working properly than would be possible for the revision time allotted. Note also that the data included show that normal-size mHtt103QP is ubiquitinated in an Ltn1-dependent manner suggesting that stalling and the generation of truncated mHtt104QP species is not an absolute requirement for Ub tagging of mHtt103QP.

*Reviewer \#1: One of the most interesting points of this work is the ability to accurately control toxic aggregate formation independent of ubiquitination of Htt. This is also the weakest point of the manuscript and few minor experiments will shore up the results. These include ubiquitin pull down experiments and probing for levels of Htt in the different mutant backgrounds.*

We have now included this analysis and show that data in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. The data further supports our previous conclusion.

*Another interesting and unexpected finding is that loss of Tae2 in the Ltn1 mutant background restores IB formation and reduces toxicity. The main question to understand is whether the IB formed in the case is identical to the IB formed in the wild type setting (i.e. it is not ubiquitinated). It would excellent if solubility of the IBs could be measured (FRAP analysis for example). Also, are the IBs found in the ltn1 tae2 mutant also wrapped in actin cables?*

We have performed this FRAP experiment as suggested and the data is included in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}. We found that the dynamics/exchange within the IBs in *ltn1Δtae2Δ* double mutant (and the other mutants analyzed) are similar to those of Wt cells and that the IBs/aggregates co-localize with dense actin structure (see [Figure 2---figure supplement 5](#fig2s5){ref-type="fig"}).

*Finally, the role of sf-1 in this process is not fully detailed or alternative possibilities suggested. One thought to explain the dose dependency observed here could involve the idea that hsf-1 is a repressor of lt.-1 or rqc1 expression. The analysis with the transactivation domain mutation of hsf-1 cannot address this possibility.* We agree that the exact mechanistic role of Hsf1 in RQC-dependent IB formation is not clear and could include indirect effects and/or effects on regulating the levels and or activity of the RQC system. We have added comments related to this in the text. That Hsf1 would act as a repressor of *LTN1* cannot fully explain the results, however, as the suppression of the *ltn1∆* phenotype by a *tae2* deletion (reducing Hsf1 activity) occurs in cells lacking Ltn1.

*Reviewer \#2: General comments:*

*The authors have presented the surprising finding that RQC deficiency renders cells deficient in sequestering mHtt proteins into IBs. This effect correlates with toxicity. However, the current manuscript does not differentiate between a direct or indirect role of RQC components in IB formation. RQC deficient cells may have a general proteostasis impairment resulting in failure of the actin cytoskeleton to mediate IB formation. Such proteostasis impairment may not occur (or be less pronounced) in the TAE2 deletion strain, consistent with the absence of HSF1 activation in that strain (Brandman et al.). The finding that HSF1 activation (or suppression) reduces IB formation independently of RQC deficiency could be merely correlative. These aspects should be discussed in more detail. Another important question relates to the interesting possibility that Ltn1 is directly involved in mHtt ubiquitination (also see below). Specific comments:*

1\) Data quality of mHtt ubiquitination in [Figure 2B](#fig2){ref-type="fig"} should be improved. His-ubiquitin pull-down analysis from RQC deficient cells expressing mHtt could be used.

His-Ub pull-down analysis has been performed and included as suggested; the data is included in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. The data supports the previous conclusions.

*2) Biochemical analysis following cycloheximide chase or metabolic chase should be performed to determine the stability of mHtt in LTN1 deletion cells.*

This has been included in [Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}.

*3) Does Ltn1 deficiency cause abnormal actin cytoskeletal structures and reduced endocytosis independently of mHtt expression?*

We have added this analysis and found that Ltn1-deficiency alone does not affect actin cytoskeletal integrity. The effect of *ltn1∆* is epistatic with mHtt103QP. The data has been included in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

*4) What is the cut-off criteria for the HCM-based screen in [Supplementary files 1](#SD1-data){ref-type="supplementary-material"} and [2](#SD2-data){ref-type="supplementary-material"}?*

The cut-off for HCM-based screen ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) is 3 times of the variation of Wt class 3 values. The cut-off for SGA ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}) is -0.5 in the score from the screen. We have added information on this in the Methods section.

*Reviewer \#3: This is a very elegant study and the findings reported in this manuscript are new and very exciting. However, there are a few points that the authors should address prior to publication. 1) Ltn1 and other RQC components associate with disassembled 60S subunits that carry stalled nascent chains which are ubiquitinated by Ltn1 and turned over by the proteasome (Bengtson & Joazeiro, 2010). In this manuscript it remains unclear whether Ltn1 and other components of the RQC contribute directly or indirectly to the change in aggregate morphology and size and the toxicity of mHtt. Different scenarios are possible that are not mutually exclusive:*

*Expression of mHtt itself may cause stalling of translation and the production of truncated mHtt versions may induce Hsf1. Both, Hsf1 activity and truncated mHtt polypeptides, may contribute to alter aggregate morphology and mHtt toxicity.*

*Alternatively, expression of mHtt may challenge proteostasis in a more general manner (e.g. chaperone activities, proteasome activities etc.) and generally enhance stalling events that are handled by the RQC and induce Hsf1 activity. Thus, is it merely an indirect effect through HSR activation, followed e.g. by an increase in molecular chaperones, that holds the mHtt aggregates in an oligomeric, toxic state?*

We agree with the reviewer that all these scenarios are possible and the data cannot exclude any of them at this point. We have expanded the Discussion to acknowledge these possibilities.

in vivo

We tried Westerns with anti-FLAG antibody but did not see any *ltn1Δ*-specific band. In addition, even though we detected smaller bands, we cannot exclude the possibility of degradation products.

*In this context, recent publications that reconstitute the ubiquitination pathway at the ribosome and solved crystal structures of Ltn1 associated with 60S-RNCs should be considered briefly in the discussion (Shao & Hegde, 2013; Shao et al., 2015; Lyumkis et al., 2014; Shen et al. 2015).*

We have added text on this as suggested.

2\) This point relates to data shown [Figure 2B and 2C](#fig2){ref-type="fig"}: [Figure 2B](#fig2){ref-type="fig"} shows the ubiquitination of mHtt (103QP). It is unclear whether ubiquitination of soluble or aggregated 103QP is detected in the blot. Is this really ubiquitination of full-length mHtt (103QP) or of a truncated mHtt arrest product? Why is the ubiquitin signal different in wt compared to tae2∆? Could this argue for truncated mHtt products that lack the cat tail in tae2 mutant cells (see Shen et al., Science 2015)?

*Please also include an immunoblot monitoring Ltn1 expression levels, especially when expressed from a plasmid.*

His-Ub pulled-down experiments has been performed for whole protein lysate and the results support our findings in [Figure 2B](#fig2){ref-type="fig"}. Also, the pulled-down product shows the same size in Wt and *tae2∆*.

[Figure 2C](#fig2){ref-type="fig"} shows the stability of mHtt in wt and ltn1∆ cells and the authors conclude that mHtt was equally stable in both strains. Does the readout include soluble AND/OR aggregated mHtt species? The readout was done by GFP activity (fused to mHtt). Thus, it may mainly report on insoluble aggregates of mHtt which show also GFP activity and of course remain rather stable! Moreover, the mHtt portion might be degraded by the proteasome but not the folded GFP moiety.

*This experiment has to be re-designed to look directly to mHtt in the soluble vs. aggregated fraction in the presence and absence of Ltn1.*

Western-based cycloheximide chase experiment has now been included for both soluble and aggregated mHtt. The data is included in Figure 3---figure supplement 4. The data show that mHtt (soluble and aggregated) is not more stable in the *ltn1* mutant and that the total levels of mHtt is, in fact, somewhat lower in the *ltn1* mutant. Thus, the toxicity observed in Ltn1-deficient cells is not linked to elevated levels/stability of the protein.
